Experimental Treatment Denial Appeal Letter Template
When your insurer labels a treatment as 'experimental' or 'investigational,' it can feel like a dead end. But many treatments denied as experimental are actually well-supported by clinical evidence. This template helps you build the case.
Letter Template: Experimental Treatment Appeal
[Your Name]
[Your Address]
[City, State ZIP]
[Date]
[Insurance Company Name]
[Appeals Department]
[Address]
Re: Appeal of Denial — Experimental/Investigational
Member Name: [Your Name]
Member ID: [Your ID Number]
Claim/Reference Number: [Number]
Denied Treatment: [Treatment Name]
Dear Appeals Review Committee:
I am writing to formally appeal the denial of [treatment]
dated [denial date], which was classified as "experimental"
or "investigational." I submit evidence demonstrating that
this treatment is supported by substantial clinical evidence
and meets accepted standards of medical practice.
FDA STATUS
[If FDA-approved for any indication: Treatment is
FDA-approved for [indication]. Off-label use for
[your condition] is supported by...]
CLINICAL EVIDENCE
- [Peer-reviewed study 1 — citation and key findings]
- [Peer-reviewed study 2]
- [Clinical practice guidelines recommending this treatment]
- [Drug compendia listing, if applicable]
STANDARD OF CARE
[This treatment is recognized as standard of care by:- [Medical specialty organization]
- [NCCN guidelines, if cancer-related]
- [Other authoritative sources]]
PATIENT-SPECIFIC FACTORS
[Explain why standard treatments are inadequate:- Treatments tried and failed
- Contraindications to alternatives
- Unique clinical circumstances]
I respectfully request reversal of this denial.
Sincerely,
[Your Name]
Key Strategies
- Check drug compendia — UpToDate, NCCN, Micromedex, AHFS — listing in a recognized compendium strengthens your case
- FDA approval matters — even off-label use of FDA-approved drugs is often covered
- Request external review — external reviewers specialize in the clinical area and may be more knowledgeable
- State laws — some states prohibit denying treatments that are in clinical guidelines
- Clinical trials — the ACA requires coverage of routine costs for qualifying clinical trial participants